Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 13-week, multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel group trial of lumiracoxib (COX189) 100 mg o.d. in patients with primary hip osteoarthritis using celecoxib (200 mg o.d.) as a positive control https://kusajili.com:443/Trial/NBcIq1mY9UCZ3QaWLxg0-w%24a-13-week-multicenter-randomized-double-blind-double-dummy-placebo-controlled-parallel-group-trial-of-lumiracoxib-cox189-100-mg
I have read and accept the terms of use of the site and the Privacy Policy
Send your message